Michael A. Rogawski - Publications

Affiliations: 
University of California, Davis, Davis, CA 
Area:
Neurology

221 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Guignet M, Dhakal K, Flannery BM, Hobson BA, Zolkowska D, Dhir A, Bruun DA, Li S, Wahab A, Harvey DJ, Silverman JL, Rogawski MA, Lein PJ. Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication. Neurobiology of Disease. PMID 30905768 DOI: 10.1016/j.nbd.2019.03.019  1
2018 Dhir A, Rogawski MA. Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats. Epilepsia. PMID 29682729 DOI: 10.1111/epi.14069  1
2018 Zolkowska D, Wu CY, Rogawski MA. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus. Epilepsia. PMID 29453777 DOI: 10.1111/epi.13999  1
2017 Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, ... ... Rogawski MA, et al. Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia. PMID 29247482 DOI: 10.1111/epi.13965  1
2017 Dingledine R, Coulter DA, Fritsch B, Gorter JA, Lelutiu N, McNamara J, Nadler JV, Pitkänen A, Rogawski MA, Skene P, Sloviter RS, Wang Y, Wadman WJ, Wasterlain C, Roopra A. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Scientific Data. 4: 170061. PMID 28485718 DOI: 10.1038/sdata.2017.61  0.8
2016 Pessah IN, Rogawski MA, Tancredi DJ, Wulff H, Zolkowska D, Bruun DA, Hammock BD, Lein PJ. Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents. Annals of the New York Academy of Sciences. PMID 27467073 DOI: 10.1111/nyas.13137  1
2016 Rogawski MA. A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. Brain : a Journal of Neurology. 139: 306-9. PMID 26912516 DOI: 10.1093/brain/awv369  1
2016 Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harbor Perspectives in Medicine. PMID 26801895 DOI: 10.1101/cshperspect.a022780  1
2015 Mintzer S, French JA, Perucca E, Cramer JA, Messenheimer JA, Blum DE, Rogawski MA, Baulac M. Is a separate monotherapy indication warranted for antiepileptic drugs? The Lancet. Neurology. 14: 1229-40. PMID 26581972 DOI: 10.1016/S1474-4422(15)00229-X  1
2015 Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology. PMID 26525567 DOI: 10.1007/s00213-015-4115-7  0.36
2015 Desai R, Savechenkov PY, Zolkowska D, Ge RL, Rogawski MA, Bruzik KS, Forman SA, Raines DE, Miller KW. Contrasting actions of a convulsant barbiturate and its anti-convulsant enantiomer on the α1β3γ2L GABAA receptor account for their in vivo effects. The Journal of Physiology. PMID 26378885 DOI: 10.1113/JP270971  1
2015 Irwin RW, Solinsky CM, Loya CM, Salituro FG, Rodgers KE, Bauer G, Rogawski MA, Brinton RD. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. Plos One. 10: e0128313. PMID 26039057 DOI: 10.1371/journal.pone.0128313  1
2015 Bruun DA, Cao Z, Inceoglu B, Vito ST, Austin AT, Hulsizer S, Hammock BD, Tancredi DJ, Rogawski MA, Pessah IN, Lein PJ. Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. Neuropharmacology. 95: 332-42. PMID 25882826 DOI: 10.1016/j.neuropharm.2015.03.035  1
2015 Coleman N, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN, Wulff H. The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 234-49. PMID 25256961 DOI: 10.1007/s13311-014-0305-y  1
2014 Vito ST, Austin AT, Banks CN, Inceoglu B, Bruun DA, Zolkowska D, Tancredi DJ, Rogawski MA, Hammock BD, Lein PJ. Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. Toxicology and Applied Pharmacology. 281: 185-94. PMID 25448683 DOI: 10.1016/j.taap.2014.10.001  1
2014 Broomall E, Natale JE, Grimason M, Goldstein J, Smith CM, Chang C, Kanes S, Rogawski MA, Wainwright MS. Pediatric super-refractory status epilepticus treated with allopregnanolone. Annals of Neurology. 76: 911-5. PMID 25363147 DOI: 10.1002/ana.24295  1
2014 Chen CY, Matt L, Hell JW, Rogawski MA. Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons. Plos One. 9: e108021. PMID 25229608 DOI: 10.1371/journal.pone.0108021  1
2014 Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 5765-75. PMID 24760837 DOI: 10.1523/JNEUROSCI.5307-13.2014  1
2014 Zolkowska D, Dhir A, Krishnan K, Covey DF, Rogawski MA. Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms. Psychopharmacology. 231: 3325-32. PMID 24705905 DOI: 10.1007/s00213-014-3546-x  1
2014 Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 385-400. PMID 24671870 DOI: 10.1007/s13311-014-0266-1  1
2013 Inceoglu B, Zolkowska D, Yoo HJ, Wagner KM, Yang J, Hackett E, Hwang SH, Lee KS, Rogawski MA, Morisseau C, Hammock BD. Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures. Plos One. 8: e80922. PMID 24349022 DOI: 10.1371/journal.pone.0080922  1
2013 Rogawski MA, Loya CM, Reddy K, Zolkowska D, Lossin C. Neuroactive steroids for the treatment of status epilepticus. Epilepsia. 54: 93-8. PMID 24001085 DOI: 10.1111/epi.12289  1
2013 Wilcox KS, Dixon-Salazar T, Sills GJ, Ben-Menachem E, White HS, Porter RJ, Dichter MA, Moshé SL, Noebels JL, Privitera MD, Rogawski MA. Issues related to development of new antiseizure treatments. Epilepsia. 54: 24-34. PMID 23909851 DOI: 10.1111/epi.12296  1
2013 Galanopoulou AS, Kokaia M, Loeb JA, Nehlig A, Pitkänen A, Rogawski MA, Staley KJ, Whittemore VH, Dudek FE. Epilepsy therapy development: technical and methodologic issues in studies with animal models. Epilepsia. 54: 13-23. PMID 23909850 DOI: 10.1111/epi.12295  1
2013 Bröer S, Zolkowska D, Gernert M, Rogawski MA. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat. Neuroscience. 252: 253-61. PMID 23906638 DOI: 10.1016/j.neuroscience.2013.07.050  1
2013 Dhir A, Zolkowska D, Rogawski MA. Seizure protection by intrapulmonary delivery of midazolam in mice. Neuropharmacology. 73: 425-31. PMID 23774136 DOI: 10.1016/j.neuropharm.2013.06.002  1
2013 Gasior M, Tang R, Rogawski MA. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats. The Journal of Pharmacology and Experimental Therapeutics. 346: 528-34. PMID 23772062 DOI: 10.1124/jpet.113.205070  1
2013 Rogawski MA. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs. Epilepsia. 54: 33-40. PMID 23646969 DOI: 10.1111/epi.12182  1
2013 Rogawski MA, Hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurologica Scandinavica. Supplementum. 19-24. PMID 23480152 DOI: 10.1111/ane.12100  1
2013 Rogawski MA. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurologica Scandinavica. Supplementum. 9-18. PMID 23480151 DOI: 10.1111/ane.12099  1
2013 Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends in Neurosciences. 36: 174-84. PMID 23298414 DOI: 10.1016/j.tins.2012.11.008  1
2012 Löscher W, Rogawski MA. How theories evolved concerning the mechanism of action of barbiturates. Epilepsia. 53: 12-25. PMID 23205959 DOI: 10.1111/epi.12025  1
2012 Porter RJ, Dhir A, Macdonald RL, Rogawski MA. Mechanisms of action of antiseizure drugs. Handbook of Clinical Neurology. 108: 663-81. PMID 22939059 DOI: 10.1016/B978-0-444-52899-5.00021-6  1
2012 Lossin C, Nam TS, Shahangian S, Rogawski MA, Choi SY, Kim MK, Sunwoo IN. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome. Neurology. 79: 1033-40. PMID 22914841 DOI: 10.1212/WNL.0b013e3182684683  1
2012 Cao Z, Hammock BD, McCoy M, Rogawski MA, Lein PJ, Pessah IN. Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 130: 362-72. PMID 22889812 DOI: 10.1093/toxsci/kfs244  1
2012 French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 79: 589-96. PMID 22843280 DOI: 10.1212/WNL.0b013e3182635735  1
2012 Lossin C, Shi X, Rogawski MA, Hirose S. Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T. Neurobiology of Disease. 47: 378-84. PMID 22677033 DOI: 10.1016/j.nbd.2012.05.017  1
2012 Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Human Molecular Genetics. 21: 2923-35. PMID 22466801 DOI: 10.1093/hmg/dds118  1
2012 Dhir A, Lossin C, Rogawski MA. Propofol hemisuccinate suppresses cortical spreading depression. Neuroscience Letters. 514: 67-70. PMID 22390898 DOI: 10.1016/j.neulet.2012.02.058  1
2012 Zolkowska D, Banks CN, Dhir A, Inceoglu B, Sanborn JR, McCoy MR, Bruun DA, Hammock BD, Lein PJ, Rogawski MA. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. The Journal of Pharmacology and Experimental Therapeutics. 341: 435-46. PMID 22328574 DOI: 10.1124/jpet.111.190579  1
2012 Dhir A, Rogawski MA. Role of neurosteroids in the anticonvulsant activity of midazolam. British Journal of Pharmacology. 165: 2684-91. PMID 22014182 DOI: 10.1111/j.1476-5381.2011.01733.x  1
2011 Rogawski MA, Federoff HJ. Disclosure of clinical trial results when product development is abandoned. Science Translational Medicine. 3: 102cm29. PMID 21957167 DOI: 10.1126/scitranslmed.3002939  1
2011 Stafstrom CE, Arnason BG, Baram TZ, Catania A, Cortez MA, Glauser TA, Pranzatelli MR, Riikonen R, Rogawski MA, Shinnar S, Swann JW. Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. Journal of Child Neurology. 26: 1411-21. PMID 21719797 DOI: 10.1177/0883073811413129  1
2011 Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Currents / American Epilepsy Society. 11: 56-63. PMID 21686307 DOI: 10.5698/1535-7511-11.2.56  1
2011 Rogawski MA. A new policy for disclosure of competing interests. Epilepsy Currents / American Epilepsy Society. 11: 7-8. PMID 21461259  1
2011 Kaminski RM, Rogawski MA. 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology. 61: 133-7. PMID 21458468 DOI: 10.1016/j.neuropharm.2011.03.019  1
2011 Dhir A, Zolkowska D, Murphy RB, Rogawski MA. Seizure protection by intrapulmonary delivery of propofol hemisuccinate. The Journal of Pharmacology and Experimental Therapeutics. 336: 215-22. PMID 20837991 DOI: 10.1124/jpet.110.173591  1
2010 Reddy DS, Rogawski MA. Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy. Epilepsia. 51: 84. PMID 25147407 DOI: 10.1111/j.1528-1167.2010.02870.x  1
2010 Noebels JL, Avoli M, Rogawski M, Olsen R, Delgado-Escueta AV. "Jasper's Basic Mechanisms of the Epilepsies" Workshop. Epilepsia. 51: 1-5. PMID 21208201 DOI: 10.1111/j.1528-1167.2010.02792.x  1
2010 Gasior M, Yankura J, Hartman AL, French A, Rogawski MA. Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia. 51: 1385-94. PMID 20491877 DOI: 10.1111/j.1528-1167.2010.02593.x  1
2010 Reddy DS, Rogawski MA. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Research. 89: 254-60. PMID 20172694 DOI: 10.1016/j.eplepsyres.2010.01.009  1
2010 Fritsch B, Stott JJ, Joelle Donofrio J, Rogawski MA. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. Epilepsia. 51: 108-17. PMID 19682025 DOI: 10.1111/j.1528-1167.2009.02205.x  1
2010 Rogawski MA. Migraine and epilepsy: Shared mechanisms? Epilepsia. 51: 80. DOI: 10.1111/j.1528-1167.2010.02866.x  1
2010 Faden AI, Bakshi R, Rogawski MA. Neurotherapeutics to publish primary research papers Neurotherapeutics. 7: 229. DOI: 10.1016/j.nurt.2010.05.009  1
2009 Schachter SC, Guttag J, Schiff SJ, Schomer DL. Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit. Epilepsy & Behavior : E&B. 16: 3-46. PMID 19780225 DOI: 10.1016/j.yebeh.2009.06.028  1
2009 Runyon SP, Orr M, Navarro HA, Kepler JA, Rogawski MA, Kaminski RM, Cook CE. 17beta-Nitro-5alpha-androstan-3alpha-ol and its 3beta-methyl derivative: neurosteroid analogs with potent anticonvulsant and anxiolytic activities. European Journal of Pharmacology. 617: 68-73. PMID 19577558 DOI: 10.1016/j.ejphar.2009.06.052  1
2009 Fritsch B, Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Rogawski MA, Braga MF. Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience. 163: 415-29. PMID 19540312 DOI: 10.1016/j.neuroscience.2009.06.034  1
2009 Braga MF, Aroniadou-Anderjaska V, Li H, Rogawski MA. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. The Journal of Pharmacology and Experimental Therapeutics. 330: 558-66. PMID 19417176 DOI: 10.1124/jpet.109.153908  1
2009 Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 392-401. PMID 19332335 DOI: 10.1016/j.nurt.2009.01.006  1
2009 Rogawski MA. Convection-enhanced delivery in the treatment of epilepsy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 344-51. PMID 19332329 DOI: 10.1016/j.nurt.2009.01.017  1
2009 Rogawski MA, Holmes GL. Nontraditional epilepsy treatment approaches. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 213-7. PMID 19332312 DOI: 10.1016/j.nurt.2009.02.002  1
2009 Biagini G, Longo D, Baldelli E, Zoli M, Rogawski MA, Bertazzoni G, Avoli M. Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia. 50: 53-8. PMID 19125849 DOI: 10.1111/j.1528-1167.2008.01971.x  1
2008 Rogawski MA, Bazil CW. New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Current Neurology and Neuroscience Reports. 8: 345-52. PMID 18590620 DOI: 10.1007/s11910-008-0053-7  1
2008 Rogawski MA. Brivaracetam: a rational drug discovery success story. British Journal of Pharmacology. 154: 1555-7. PMID 18552880 DOI: 10.1038/bjp.2008.221  1
2008 Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Archives of Neurology. 65: 709-14. PMID 18541791 DOI: 10.1001/archneur.65.6.709  1
2008 Gasior M, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone does not depend upon its metabolites. Epilepsia. 49: 936-7. PMID 18454785 DOI: 10.1111/j.1528-1167.2007.01518_3.x  1
2008 Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T, Rogawski M, Gasior M, Luckenbaugh D, Chen G, Manji HK. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Molecular Psychiatry. 13: 858-72. PMID 18332879 DOI: 10.1038/mp.2008.20  1
2008 Hartman AL, Lyle M, Rogawski MA, Gasior M. Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia. 49: 334-9. PMID 18070095 DOI: 10.1111/j.1528-1167.2007.01430.x  1
2008 Rogawski MA. Common mechanisms in migraine and epilepsy: A comment - Reply Archives of Neurology. 65: 1546-1547.  1
2007 Gasior M, White NA, Rogawski MA. Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA. The Journal of Pharmacology and Experimental Therapeutics. 323: 458-68. PMID 17717191 DOI: 10.1124/jpet.107.125047  1
2007 Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatric Neurology. 36: 281-92. PMID 17509459 DOI: 10.1016/j.pediatrneurol.2007.02.008  1
2007 Rho JM, Rogawski MA. The ketogenic diet: stoking the powerhouse of the cell. Epilepsy Currents / American Epilepsy Society. 7: 58-60. PMID 17505556 DOI: 10.1111/j.1535-7511.2007.00170.x  1
2007 Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia. 48: 793-800. PMID 17386058 DOI: 10.1111/j.1528-1167.2007.01026.x  1
2007 Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 4: 18-61. PMID 17199015 DOI: 10.1016/j.nurt.2006.11.010  1
2006 Rogawski MA, Suber P. Support for the NIH public access policy. Science (New York, N.Y.). 313: 1572. PMID 16973859 DOI: 10.1126/science.313.5793.1572a  1
2006 Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behavioural Pharmacology. 17: 431-9. PMID 16940764 DOI: 10.1097/00008877-200609000-00009  1
2006 Biagini G, Baldelli E, Longo D, Pradelli L, Zini I, Rogawski MA, Avoli M. Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Experimental Neurology. 201: 519-24. PMID 16780839 DOI: 10.1016/j.expneurol.2006.04.029  1
2006 Rogawski MA. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Research. 69: 273-94. PMID 16621450 DOI: 10.1016/j.eplepsyres.2006.02.004  1
2006 Kaminski RM, Marini H, Ortinski PI, Vicini S, Rogawski MA. The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors. The Journal of Pharmacology and Experimental Therapeutics. 317: 694-703. PMID 16415088 DOI: 10.1124/jpet.105.098319  1
2006 Rogawski MA. Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Research. 68: 22-8. PMID 16377151 DOI: 10.1016/j.eplepsyres.2005.09.012  1
2006 N'Gouemo P, Rogawski MA. Alcohol Withdrawal Seizures Models of Seizures and Epilepsy. 161-177. DOI: 10.1016/B978-012088554-1/50015-3  1
2005 Rogawski MA. Astrocytes get in the act in epilepsy. Nature Medicine. 11: 919-20. PMID 16145568 DOI: 10.1038/nm0905-919  1
2005 Gryder DS, Castaneda DC, Rogawski MA. Evidence for low GluR2 AMPA receptor subunit expression at synapses in the rat basolateral amygdala. Journal of Neurochemistry. 94: 1728-38. PMID 16045445 DOI: 10.1111/j.1471-4159.2005.03334.x  1
2005 Kaminski RM, Marini H, Kim WJ, Rogawski MA. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia. 46: 819-27. PMID 15946323 DOI: 10.1111/j.1528-1167.2005.00705.x  1
2005 Winitsky SO, Gopal TV, Hassanzadeh S, Takahashi H, Gryder D, Rogawski MA, Takeda K, Yu ZX, Xu YH, Epstein ND. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. Plos Biology. 3: e87. PMID 15757365 DOI: 10.1371/journal.pbio.0030087  1
2005 Reddy DS, O'Malley BW, Rogawski MA. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology. 48: 14-24. PMID 15617723 DOI: 10.1016/j.neuropharm.2004.09.002  1
2004 Ivanov SV, Ward JM, Tessarollo L, McAreavey D, Sachdev V, Fananapazir L, Banks MK, Morris N, Djurickovic D, Devor-Henneman DE, Wei MH, Alvord GW, Gao B, Richardson JA, Minna JD, ... Rogawski MA, et al. Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. The American Journal of Pathology. 165: 1007-18. PMID 15331424 DOI: 10.1016/S0002-9440(10)63362-7  1
2004 Rogawski MA. What is the rationale for new treatment strategies in Alzheimer's disease? Cns Spectrums. 9: 6-12. PMID 15241294  1
2004 Kaminski RM, Livingood MR, Rogawski MA. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia. 45: 864-7. PMID 15230714 DOI: 10.1111/j.0013-9580.2004.04504.x  1
2004 Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Medicine. 10: 685-92. PMID 15229516 DOI: 10.1038/nm1074  1
2004 Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nature Reviews. Neuroscience. 5: 553-64. PMID 15208697 DOI: 10.1038/nrn1430  1
2004 Kaminski RM, Banerjee M, Rogawski MA. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology. 46: 1097-104. PMID 15111016 DOI: 10.1016/j.neuropharm.2004.02.010  1
2004 Reddy DS, Castaneda DC, O'Malley BW, Rogawski MA. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. The Journal of Pharmacology and Experimental Therapeutics. 310: 230-9. PMID 14982969 DOI: 10.1124/jpet.104.065268  1
2003 Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. Cns Drug Reviews. 9: 275-308. PMID 14530799  1
2003 Salazar P, Tapia R, Rogawski MA. Effects of neurosteroids on epileptiform activity induced by picrotoxin and 4-aminopyridine in the rat hippocampal slice. Epilepsy Research. 55: 71-82. PMID 12948618 DOI: 10.1016/S0920-1211(03)00112-8  1
2003 Gryder DS, Rogawski MA. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 7069-74. PMID 12904467  1
2003 Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, Novotny EJ, Gropman A, Conry JA, Berry GT, Tuchman M. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology. 60: 1413-7. PMID 12743223  1
2003 Rogawski MA, Gryder D, Castaneda D, Yonekawa W, Banks MK, Lia H. GluR5 kainate receptors, seizures, and the amygdala. Annals of the New York Academy of Sciences. 985: 150-62. PMID 12724156  1
2003 Rogawski MA. Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy. Annals of Neurology. 53: 288-91. PMID 12601696 DOI: 10.1002/ana.10534  1
2002 Rogawski MA. Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs? Epilepsy & Behavior : E&B. 3: 493-495. PMID 12609240 DOI: 10.1016/S1525-5050(02)00557-7  1
2002 Pace JR, Lonser RR, Kirkby RD, Jeffries N, Rogawski MA, Oldfield EH. Epileptiform activity extinguished by amygdala infusion of the neurotoxin ibotenate in a rat model of temporal lobe epilepsy. Journal of Neurosurgery. 97: 450-4. PMID 12186475 DOI: 10.3171/jns.2002.97.2.0450  1
2002 Schmidt D, Rogawski MA. New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Research. 50: 71-8. PMID 12151119 DOI: 10.1016/S0920-1211(02)00070-0  1
2002 Rogawski MA, Reddy DS. Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis. International Review of Neurobiology. 49: 199-219. PMID 12040893  1
2002 Reddy DS, Rogawski MA. Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3795-805. PMID 11978855  1
2001 Basile AS, Koustova E, Ioan P, Rizzoli S, Rogawski MA, Usherwood PN. IgG isolated from LP-BM5 infected mouse brain activates ionotropic glutamate receptors. Neurobiology of Disease. 8: 1069-81. PMID 11741402 DOI: 10.1006/nbdi.2001.0442  1
2001 Jacobs MP, Fischbach GD, Davis MR, Dichter MA, Dingledine R, Lowenstein DH, Morrell MJ, Noebels JL, Rogawski MA, Spencer SS, Theodore WH. Future directions for epilepsy research. Neurology. 57: 1536-42. PMID 11706087  1
2001 Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia. 42: 337-44. PMID 11442150 DOI: 10.1046/j.1528-1157.2001.10200.x  1
2001 Reddy DS, Kim HY, Rogawski MA. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia. 42: 328-36. PMID 11442149 DOI: 10.1046/j.1528-1157.2001.10100.x  1
2001 Avoli M, Rogawski MA, Avanzini G. Generalized epileptic disorders: an update. Epilepsia. 42: 445-57. PMID 11440339 DOI: 10.1046/j.1528-1157.2001.39800.x  1
2001 Li H, Chen A, Xing G, Wei ML, Rogawski MA. Kainate receptor-mediated heterosynaptic facilitation in the amygdala. Nature Neuroscience. 4: 612-20. PMID 11369942 DOI: 10.1038/88432  1
2001 Koustova E, Sei Y, Fossom L, Wei ML, Usherwood PN, Keele NB, Rogawski MA, Basile AS. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor. The Journal of Clinical Investigation. 107: 737-44. PMID 11254673 DOI: 10.1172/JCI11500  1
2001 Aroniadou-Anderjaska V, Post RM, Rogawski MA, Li H. Input-specific LTP and depotentiation in the basolateral amygdala. Neuroreport. 12: 635-40. PMID 11234779  1
2001 Rogawski MA, Kurzman PS, Yamaguchi SI, Li H. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse. Neuropharmacology. 40: 28-35. PMID 11077068 DOI: 10.1016/S0028-3908(00)00112-X  1
2000 Reddy DS, Rogawski MA. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. The Journal of Pharmacology and Experimental Therapeutics. 295: 1241-8. PMID 11082461  1
2000 Rogawski MA. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability. Amino Acids. 19: 133-49. PMID 11026482 DOI: 10.1007/s007260070042  1
2000 Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. The Journal of Pharmacology and Experimental Therapeutics. 294: 909-15. PMID 10945840  1
2000 Rogawski MA. KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends in Neurosciences. 23: 393-8. PMID 10941184 DOI: 10.1016/S0166-2236(00)01629-5  1
2000 Rogawski MA, Wasterlain CG, Mazarati AM. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor". Epilepsia. 41: 918-9. PMID 10897169  1
2000 Mothet JP, Parent AT, Wolosker H, Brady RO, Linden DJ, Ferris CD, Rogawski MA, Snyder SH. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proceedings of the National Academy of Sciences of the United States of America. 97: 4926-31. PMID 10781100 DOI: 10.1073/pnas.97.9.4926  1
2000 Harty TP, Rogawski MA. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Research. 39: 47-55. PMID 10690753 DOI: 10.1016/S0920-1211(99)00108-4  1
1999 Rogawski MA, Donevan SD. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Advances in Neurology. 79: 947-63. PMID 10514878  1
1999 Kokate TG, Juhng KN, Kirkby RD, Llamas J, Yamaguchi S, Rogawski MA. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Research. 831: 119-24. PMID 10411990 DOI: 10.1016/S0006-8993(99)01287-1  1
1999 Juhng KN, Kokate TG, Yamaguchi S, Kim BY, Rogowski RS, Blaustein MP, Rogawski MA. Induction of seizures by the potent K+ channel-blocking scorpion venom peptide toxins tityustoxin-K(alpha) and pandinustoxin-K(alpha). Epilepsy Research. 34: 177-86. PMID 10210033 DOI: 10.1016/S0920-1211(98)00111-9  1
1999 Kokate TG, Banks MK, Magee T, Yamaguchi S, Rogawski MA. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. The Journal of Pharmacology and Experimental Therapeutics. 288: 679-84. PMID 9918575  1
1998 Li H, Rogawski MA. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro. Neuropharmacology. 37: 1279-86. PMID 9849665 DOI: 10.1016/S0028-3908(98)00109-9  1
1998 Kokate TG, Yamaguchi S, Pannell LK, Rajamani U, Carroll DM, Grossman AB, Rogawski MA. Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. The Journal of Pharmacology and Experimental Therapeutics. 287: 553-8. PMID 9808680  1
1998 Donevan SD, Rogawski MA. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines. Neuroscience. 87: 615-29. PMID 9758228 DOI: 10.1016/S0306-4522(98)00109-2  1
1998 Grauert M, Rho JM, Subramaniam S, Rogawski MA. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL. The Journal of Pharmacology and Experimental Therapeutics. 285: 767-76. PMID 9580625  1
1998 Li H, Weiss SR, Chuang DM, Post RM, Rogawski MA. Bidirectional synaptic plasticity in the rat basolateral amygdala: characterization of an activity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor antagonist 2S-alpha-ethylglutamic acid. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1662-70. PMID 9464991  1
1998 Rogawski MA. Mechanism-specific pathways for new antiepileptic drug discovery. Advances in Neurology. 76: 11-27. PMID 9408460  1
1997 Rho JM, Donevan SD, Rogawski MA. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. The Journal of Pharmacology and Experimental Therapeutics. 280: 1383-91. PMID 9067327  1
1996 Kokate TG, Cohen AL, Karp E, Rogawski MA. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology. 35: 1049-56. PMID 9121607 DOI: 10.1016/S0028-3908(96)00021-4  1
1996 Grant KA, Colombo G, Grant J, Rogawski MA. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists. Neuropharmacology. 35: 1709-19. PMID 9076750 DOI: 10.1016/S0028-3908(96)00147-5  1
1996 Rho JM, Donevan SD, Rogawski MA. Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. The Journal of Physiology. 497: 509-22. PMID 8961191  1
1996 Poling JS, Rogawski MA, Salem N, Vicini S. Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels. Neuropharmacology. 35: 983-91. PMID 8938728 DOI: 10.1016/0028-3908(96)00130-X  1
1996 Poling JS, Vicini S, Rogawski MA, Salem N. Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc. Neuropharmacology. 35: 969-82. PMID 8938727 DOI: 10.1016/0028-3908(96)00127-X  1
1996 Levitan IB, Rogawski MA. Potassium channels. Neuropharmacology. 35: 759. PMID 8938708  1
1996 Rogowski RS, Collins JH, O'Neill TJ, Gustafson TA, Werkman TR, Rogawski MA, Tenenholz TC, Weber DJ, Blaustein MP. Three new toxins from the scorpion Pandinus imperator selectively block certain voltage-gated K+ channels. Molecular Pharmacology. 50: 1167-77. PMID 8913348  1
1996 Donevan SD, Rogawski MA. Multiple actions of arylalkylamine arthropod toxins on the N-methyl-D-aspartate receptor. Neuroscience. 70: 361-75. PMID 8848146  1
1996 Chen K, Kokate TG, Donevan SD, Carroll FI, Rogawski MA. Ibogaine block of the NMDA receptor: in vitro and in vivo studies. Neuropharmacology. 35: 423-31. PMID 8793904 DOI: 10.1016/0028-3908(96)84107-4  1
1996 Subramaniam S, Donevan SD, Rogawski MA. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite. The Journal of Pharmacology and Experimental Therapeutics. 276: 161-8. PMID 8558426  1
1996 Hough CJ, Irwin RP, Gao XM, Rogawski MA, Chuang DM. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. The Journal of Pharmacology and Experimental Therapeutics. 276: 143-9. PMID 8558424  1
1996 Levitan IB, Rogawski MA. Editorial Neuropharmacology. 35: 759.  1
1996 Rho JM, Donevan SD, Rogawski MA. Direct activation of GABA(A) receptors by barbiturates in cultured rat hippocampal neurons Journal of Physiology. 497: 509-522.  1
1995 Lapin IP, Rogawski MA. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Behavioural Brain Research. 70: 145-51. PMID 8561905 DOI: 10.1016/0166-4328(95)80004-2  1
1995 Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA. Felbamate block of the N-methyl-D-aspartate receptor. The Journal of Pharmacology and Experimental Therapeutics. 273: 878-86. PMID 7752093  1
1995 Donevan SD, Rogawski MA. Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proceedings of the National Academy of Sciences of the United States of America. 92: 9298-302. PMID 7568121  1
1995 Rogawski MA, Le DQ, Uyakul D, Pannell LK, Subramaniam S, Yamaguchi S, Kokate TG. Anticonvulsant efficacy of ADCI (5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine) after acute and chronic dosing in mice. Epilepsia. 36: 566-71. PMID 7555968 DOI: 10.1111/j.1528-1157.1995.tb02568.x  1
1994 Subramaniam S, Donevan SD, Rogawski MA. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites. Molecular Pharmacology. 45: 117-24. PMID 8302270  1
1994 Goodman CB, Thomas DN, Pert A, Emilien B, Cadet JL, Carroll FI, Blough BE, Mascarella SW, Rogawski MA, Subramaniam S. RTI-4793-14, a new ligand with high affinity and selectivity for the (+)-MK801-insensitive [3H]1-]1-(2-thienyl)cyclohexyl]piperidine binding site (PCP site 2) of guinea pig brain. Synapse (New York, N.Y.). 16: 59-65. PMID 8134901 DOI: 10.1002/syn.890160107  1
1994 Rho JM, Donevan SD, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors. Annals of Neurology. 35: 229-34. PMID 8109904 DOI: 10.1002/ana.410350216  1
1994 McRae KD. Riluzole in amyotrophic lateral sclerosis. The New England Journal of Medicine. 331: 272-3; author reply . PMID 8015578 DOI: 10.1056/NEJM199407283310413  1
1994 Irwin RP, Lin SZ, Rogawski MA, Purdy RH, Paul SM. Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies. The Journal of Pharmacology and Experimental Therapeutics. 271: 677-82. PMID 7965782  1
1994 Sofia RD, Rho JM, Donevan SD, Subramaniam S, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: Opposing effects on N-methyl-D-aspartate and γ-aminobutyric acid(A) receptors [1] Annals of Neurology. 36: 677-678. PMID 7944305  1
1994 Svensson BE, Werkman TR, Rogawski MA. Alaproclate effects on voltage-dependent K+ channels and NMDA receptors: studies in cultured rat hippocampal neurons and fibroblast cells transformed with Kv1.2 K+ channel cDNA. Neuropharmacology. 33: 795-804. PMID 7936117 DOI: 10.1016/0028-3908(94)90119-8  1
1994 Kokate TG, Svensson BE, Rogawski MA. Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. The Journal of Pharmacology and Experimental Therapeutics. 270: 1223-9. PMID 7932175  1
1994 Mattia D, Nagao T, Rogawski MA, Avoli M. Potassium channel activators counteract anoxic hyperexcitability but not 4-aminopyridine-induced epileptiform activity in the rat hippocampal slice. Neuropharmacology. 33: 1515-22. PMID 7760973 DOI: 10.1016/0028-3908(94)90124-4  1
1994 Donevan SD, Yamaguchi S, Rogawski MA. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. The Journal of Pharmacology and Experimental Therapeutics. 271: 25-9. PMID 7525924  1
1993 Werkman TR, Gustafson TA, Rogowski RS, Blaustein MP, Rogawski MA. Tityustoxin-K alpha, a structurally novel and highly potent K+ channel peptide toxin, interacts with the alpha-dendrotoxin binding site on the cloned Kv1.2 K+ channel. Molecular Pharmacology. 44: 430-6. PMID 8355670  1
1993 ffrench-Mullen JM, Barker JL, Rogawski MA. Calcium current block by (-)-pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl- current. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 3211-21. PMID 8101867  1
1993 Yamaguchi S, Donevan SD, Rogawski MA. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Research. 15: 179-84. PMID 7693450 DOI: 10.1016/0920-1211(93)90054-B  1
1993 Donevan SD, Rogawski MA. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10: 51-9. PMID 7678966 DOI: 10.1016/0896-6273(93)90241-I  1
1993 Rogawski MA. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends in Pharmacological Sciences. 14: 325-31. PMID 7504360 DOI: 10.1016/0165-6147(93)90005-5  1
1992 Lapin IP, Rogawski MA. Muscarinic antagonists attenuate dizocilpine-induced hypermotility in mice. Life Sciences. 50: PL59-64. PMID 1740967 DOI: 10.1016/0024-3205(92)90254-M  1
1992 Yamaguchi S, Rogawski MA. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Research. 11: 9-16. PMID 1563341 DOI: 10.1016/0920-1211(92)90016-M  1
1992 Grant KA, Snell LD, Rogawski MA, Thurkauf A, Tabakoff B. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. The Journal of Pharmacology and Experimental Therapeutics. 260: 1017-22. PMID 1545374  1
1992 Blake PA, Yamaguchi S, Thurkauf A, Rogawski MA. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered. Epilepsia. 33: 188-94. PMID 1531130  1
1992 Coleman MH, Yamaguchi S, Rogawski MA. Protection against dendrotoxin-induced clonic seizures in mice by anticonvulsant drugs. Brain Research. 575: 138-42. PMID 1504773 DOI: 10.1016/0006-8993(92)90433-A  1
1992 Irwin RP, Maragakis NJ, Rogawski MA, Purdy RH, Farb DH, Paul SM. Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons. Neuroscience Letters. 141: 30-4. PMID 1387199 DOI: 10.1016/0304-3940(92)90327-4  1
1992 Porter RJ, Rogawski MA. Theoretical and practical considerations concerning the use of NMDA antagonists in the treatment of the epilepsies. Clinical Neuropharmacology. 15: 697A-698A. PMID 1386786  1
1992 Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs. 44: 279-92. PMID 1382930 DOI: 10.2165/00003495-199244030-00001  1
1992 Porter RJ, Rogawski MA. New antiepileptic drugs: from serendipity to rational discovery. Epilepsia. 33: S1-6. PMID 1379532  1
1992 Donevan SD, Jones SM, Rogawski MA. Arcaine blocks N-methyl-D-aspartate receptor responses by an open channel mechanism: whole-cell and single-channel recording studies in cultured hippocampal neurons. Molecular Pharmacology. 41: 727-35. PMID 1373801  1
1992 Ffrench-Mullen JM, Rogawski MA. Phencyclidine block of calcium current in isolated guinea-pig hippocampal neurones. The Journal of Physiology. 456: 85-105. PMID 1338108  1
1992 Pace JR, Martin BM, Paul SM, Rogawski MA. High concentrations of neutral amino acids activate NMDA receptor currents in rat hippocampal neurons. Neuroscience Letters. 141: 97-100. PMID 1324446 DOI: 10.1016/0304-3940(92)90343-6  1
1992 Subramaniam S, Donevan SD, Rogawski MA. 1,10-Diaminodecane and 1,12-diaminododecane block NMDA receptor currents by an open channel mechanism. Neuroscience Letters. 147: 213-6. PMID 1283458 DOI: 10.1016/0304-3940(92)90598-2  1
1992 Werkman TR, Kawamura T, Yokoyama S, Higashida H, Rogawski MA. Charybdotoxin, dendrotoxin and mast cell degranulating peptide block the voltage-activated K+ current of fibroblast cells stably transfected with NGK1 (Kv1.2) K+ channel complementary DNA. Neuroscience. 50: 935-46. PMID 1280351 DOI: 10.1016/0306-4522(92)90216-O  1
1992 Jones SM, Rogawski MA. The anticonvulsant (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI) selectively blocks NMDA-activated current in cultured rat hippocampal neurones: Kinetic analysis and comparison with dizocilpine Molecular Neuropharmacology. 2: 303-310.  1
1991 Rogawski MA, Yamaguchi S, Jones SM, Rice KC, Thurkauf A, Monn JA. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine. The Journal of Pharmacology and Experimental Therapeutics. 259: 30-7. PMID 1920122  1
1991 Politi DM, Rogawski MA. Glyburide-sensitive K+ channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions. Molecular Pharmacology. 40: 308-15. PMID 1715018  1
1991 Hershkowitz N, Rogawski MA. Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons. Molecular Pharmacology. 39: 592-8. PMID 1709720  1
1991 Wang XJ, Rinzel J, Rogawski MA. A model of the T-type calcium current and the low-threshold spike in thalamic neurons. Journal of Neurophysiology. 66: 839-50. PMID 1661326  1
1990 Thurkauf A, de Costa B, Yamaguchi S, Mattson MV, Jacobson AE, Rice KC, Rogawski MA. Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogues. Journal of Medicinal Chemistry. 33: 1452-8. PMID 2329567  1
1990 Rogawski MA, Hershkowitz N, Politi DM, Suzuki S, Thurkauf A, Yamaguchi S. Novel research strategies for antiepileptic therapy. Progress in Clinical and Biological Research. 361: 91-111. PMID 2290852  1
1990 Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacological Reviews. 42: 223-86. PMID 2217531  1
1989 Rogawski MA. Aminopyridines enhance opening of calcium-activated potassium channels in GH3 anterior pituitary cells. Molecular Pharmacology. 35: 458-68. PMID 2704369  1
1989 Rogawski MA, Thurkauf A, Yamaguchi S, Rice KC, Jacobson AE, Mattson MV. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline. The Journal of Pharmacology and Experimental Therapeutics. 249: 708-12. PMID 2659775  1
1989 Politi DM, Suzuki S, Rogawski MA. BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons. European Journal of Pharmacology. 168: 7-14. PMID 2583232 DOI: 10.1016/0014-2999(89)90626-2  1
1989 Hershkowitz N, Rogawski MA. Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp: antagonism at the strychnine-insensitive glycine receptor. British Journal of Pharmacology. 98: 1005-13. PMID 2556198  1
1989 ffrench-Mullen JM, Rogawski MA. Interaction of phencyclidine with voltage-dependent potassium channels in cultured rat hippocampal neurons: comparison with block of the NMDA receptor-ionophore complex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 4051-61. PMID 2555461  1
1989 Suzuki S, Rogawski MA. T-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons. Proceedings of the National Academy of Sciences of the United States of America. 86: 7228-32. PMID 2550936  1
1988 Rogawski MA, Inoue K, Suzuki S, Barker JL. A slow calcium-dependent chloride conductance in clonal anterior pituitary cells. Journal of Neurophysiology. 59: 1854-70. PMID 3404208  1
1988 ffrench-Mullen JM, Rogawski MA, Barker JL. Phencyclidine at low concentrations selectively blocks the sustained but not the transient voltage-dependent potassium current in cultured hippocampal neurons. Neuroscience Letters. 88: 325-30. PMID 3386879 DOI: 10.1016/0304-3940(88)90232-7  1
1988 Rogawski MA. Transient outward current (IA) in clonal anterior pituitary cells: blockade by aminopyridine analogs. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 125-32. PMID 3185742 DOI: 10.1007/BF00174859  1
1988 Siegel JM, Rogawski MA. A function for REM sleep: regulation of noradrenergic receptor sensitivity. Brain Research. 472: 213-33. PMID 3066435 DOI: 10.1016/0165-0173(88)90007-0  1
1988 Mollard P, Vacher P, Rogawski MA, Dufy B. Vasopressin enhances a calcium current in human ACTH-secreting pituitary adenoma cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 2: 2907-12. PMID 2844618  1
1988 Rogawski MA, Pieniek M, Suzuki S, ffrench-Mullen JM. Phencyclidine selectively blocks the sustained voltage-dependent potassium conductance in PC12 cells. Brain Research. 456: 38-48. PMID 2457411 DOI: 10.1016/0006-8993(88)90344-7  1
1988 Rogawski MA. Advances in monoaminergic transmitter systems with application in neurology Current Opinion in Neurology and Neurosurgery. 1: 547-554.  1
1987 Mollard P, Vacher P, Guerin J, Rogawski MA, Dufy B. Electrical properties of cultured human adrenocorticotropin-secreting adenoma cells: effects of high K+, corticotropin-releasing factor, and angiotensin II. Endocrinology. 121: 395-405. PMID 3036472 DOI: 10.1210/endo-121-1-395  1
1987 Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. The New England Journal of Medicine. 316: 1562-8. PMID 3035372 DOI: 10.1056/NEJM198706183162502  1
1987 Rogawski MA. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. European Journal of Pharmacology. 142: 169-72. PMID 2446884 DOI: 10.1016/0014-2999(87)90670-4  1
1987 Rogawski MA. New directions in neurotransmitter action: dopamine provides some important clues Trends in Neurosciences. 10: 200-205. DOI: 10.1016/0166-2236(87)90151-2  1
1987 Rogawski MA. Patch clamp recording of single transient outward current channels in an anterior pituitary cell line Neuroendocrinology Letters. 9: 345-352.  1
1986 Rogawski MA. Single voltage-dependent potassium channels in cultured rat hippocampal neurons. Journal of Neurophysiology. 56: 481-93. PMID 2428951  1
1985 Rogawski MA, Beinfeld MC, Hays SE, Hökfelt T, Skirboll LR. Cholecystokinin and cultured spinal neurons. Immunohistochemistry, receptor binding, and neurophysiology. Annals of the New York Academy of Sciences. 448: 403-12. PMID 2992347  1
1984 Segal M, Rogawski MA, Barker JL. A transient potassium conductance regulates the excitability of cultured hippocampal and spinal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 4: 604-9. PMID 6699688  1
1984 Rogawski MA. Transdermal scopolamine and sialorrhea. Archives of Neurology. 41: 15. PMID 6689882 DOI: 10.1001/archneur.1984.04050130017008  1
1984 Barker JL, Dufy B, Owen DG, Rogawski MA. Electrophysiological studies of peptide actions on the excitability of cultured nerve and pituitary cells. Clinical and Experimental Hypertension. Part a, Theory and Practice. 6: 1701-16. PMID 6152408 DOI: 10.3109/10641968409046064  1
1983 Rogawski MA, Barker JL. Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons. Brain Research. 280: 180-5. PMID 6652477 DOI: 10.1016/0006-8993(83)91190-3  1
1982 Rogawski MA, Aghajanian GK. Activation of lateral geniculate neurons by locus coeruleus or dorsal noradrenergic bundle stimulation: selective blockade by the alpha 1-adrenoceptor antagonist prazosin. Brain Research. 250: 31-9. PMID 7139319 DOI: 10.1016/0006-8993(82)90950-7  1
1982 Rogawski MA. Cholecystokinin octapeptide: effects on the excitability of cultured spinal neurons. Peptides. 3: 545-51. PMID 6126867 DOI: 10.1016/0196-9781(82)90124-3  1
1981 Rogawski MA, Aghajanian GK. Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 1: 1148-54. PMID 6793698  1
1980 Rogawski MA, Aghajanian GK. Norepinephrine and serotonin: opposite effects on the activity of lateral geniculate neurons evoked by optic pathway stimulation. Experimental Neurology. 69: 678-94. PMID 7409069  1
1980 Rogawski MA, Aghajanian GK. Modulation of lateral geniculate neurone excitability by noradrenaline microiontophoresis or locus coeruleus stimulation. Nature. 287: 731-4. PMID 6253811 DOI: 10.1038/287731a0  1
1980 Rogawski MA, Aghajanian GK. Activation of lateral geniculate neurons by norepinephrine: mediation by an alpha-adrenergic receptor. Brain Research. 182: 345-59. PMID 6101983 DOI: 10.1016/0006-8993(80)91193-2  1
1979 Rogawski MA, Aghajanian GK. Response of central monoaminergic neurons to lisuride: comparison with LSD. Life Sciences. 24: 1289-97. PMID 470543 DOI: 10.1016/0024-3205(79)90148-6  1
1979 Rogawski MA, Roth RH, Aghajanian GK. Melatonin: deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase. Journal of Neurochemistry. 32: 1219-26. PMID 285213 DOI: 10.1111/j.1471-4159.1979.tb11049.x  1
1978 Rogawski MA, Goodrich JT, Gershon MD, Touloukian RJ. Hirschsprung's disease: absence of serotonergic neurons in the aganglionic colon. Journal of Pediatric Surgery. 13: 608-15. PMID 731360 DOI: 10.1016/S0022-3468(78)80102-X  1
1978 Rogawski MA, Funderburk SJ, Cederbaum SD. Oculocutaneous albinism and mental disorder. A report of two autistic boys. Human Heredity. 28: 81-5. PMID 413782  1
1976 Iversen LL, Rogawski MA, Miller RJ. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Molecular Pharmacology. 12: 251-62. PMID 4724  1
1974 Rogawski MA, Knapp S, MAndell AJ. Effects of ethanol on tryptophan hydroxylase activity from striate synaptosomes. Biochemical Pharmacology. 23: 1955-62. PMID 4418689 DOI: 10.1016/0006-2952(74)90253-6  1
Show low-probability matches.